Literature DB >> 16222130

Biologic transplantation and neurotrophin-induced neuroplasticity after traumatic brain injury.

Dunyue Lu1, Asim Mahmood, Michael Chopp.   

Abstract

OBJECTIVE: In this review, we analyze progress in the treatment of traumatic brain injury with neurotrophins, growth factors and cell and tissue neurotransplantation. The primary objective of these therapies is to reduce neurologic deficits associated with the trauma by inducing neuroplasticity. These therapies are restorative and not necessarily neuroprotective. MAIN OUTCOME MEASURES: An extensive literature on administration of neurotrophics factors and cell and tissue cerebral transplantation is reviewed. The effects of these therapeutic approaches on brain biochemical, molecular, cellular, and tissue responses are summarized.
CONCLUSION: The cumulative data indicate that cell therapy shows substantial promise in the treatment of neural injury.

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 16222130     DOI: 10.1097/00001199-200307000-00006

Source DB:  PubMed          Journal:  J Head Trauma Rehabil        ISSN: 0885-9701            Impact factor:   2.710


  15 in total

1.  Role of gender in outcome after traumatic brain injury and therapeutic effect of erythropoietin in mice.

Authors:  Ye Xiong; Asim Mahmood; Dunyue Lu; Changsheng Qu; Anton Goussev; Timothy Schallert; Michael Chopp
Journal:  Brain Res       Date:  2007-10-31       Impact factor: 3.252

2.  Treatment of traumatic brain injury in mice with bone marrow stromal cell-impregnated collagen scaffolds.

Authors:  Changsheng Qu; Ye Xiong; Asim Mahmood; David L Kaplan; Anton Goussev; Ruizhuo Ning; Michael Chopp
Journal:  J Neurosurg       Date:  2009-10       Impact factor: 5.115

3.  Treatment of traumatic brain injury in mice with marrow stromal cells.

Authors:  Changsheng Qu; Asim Mahmood; Dunyue Lu; Anton Goussev; Ye Xiong; Michael Chopp
Journal:  Brain Res       Date:  2008-03-04       Impact factor: 3.252

4.  Human marrow stromal cell treatment provides long-lasting benefit after traumatic brain injury in rats.

Authors:  Asim Mahmood; Dunyue Lu; Changsheng Qu; Anton Goussev; Michael Chopp
Journal:  Neurosurgery       Date:  2005-11       Impact factor: 4.654

5.  Treatment of TBI with collagen scaffolds and human marrow stromal cells increases the expression of tissue plasminogen activator.

Authors:  Asim Mahmood; Changsheng Qu; Riuzuo Ning; Hongtao Wu; Anton Goussev; Ye Xiong; Susan Irtenkauf; Yi Li; Michael Chopp
Journal:  J Neurotrauma       Date:  2011-05-16       Impact factor: 5.269

6.  MRI evaluation of axonal reorganization after bone marrow stromal cell treatment of traumatic brain injury.

Authors:  Quan Jiang; Changsheng Qu; Michael Chopp; Guang Liang Ding; Siamak P Nejad- Davarani; Joseph A Helpern; Jens H Jensen; Zheng Gang Zhang; Lian Li; Mei Lu; David Kaplan; Jiani Hu; Yimin Shen; Zhifeng Kou; Qingjiang Li; Shiyang Wang; Asim Mahmood
Journal:  NMR Biomed       Date:  2011-03-23       Impact factor: 4.044

7.  Long-lasting benefits after treatment of traumatic brain injury (TBI) in rats with combination therapy of marrow stromal cells (MSCs) and simvastatin.

Authors:  Asim Mahmood; Anton Goussev; Dunyue Lu; Changsheng Qu; Ye Xiong; Humaira Kazmi; Michael Chopp
Journal:  J Neurotrauma       Date:  2008-12       Impact factor: 5.269

8.  Treatment of injured neurons with bone marrow stem cells cotransfected by hTERT and Ad-BDNF in vitro.

Authors:  Zhitao Wang; Quanjun Deng; Xiaohui Zhang; Jianning Zhang
Journal:  J Mol Neurosci       Date:  2009-05-21       Impact factor: 3.444

9.  Collagen scaffolds populated with human marrow stromal cells reduce lesion volume and improve functional outcome after traumatic brain injury.

Authors:  Dunyue Lu; Asim Mahmood; Changsheng Qu; Xin Hong; David Kaplan; Michael Chopp
Journal:  Neurosurgery       Date:  2007-09       Impact factor: 4.654

10.  Delayed transplantation of human marrow stromal cell-seeded scaffolds increases transcallosal neural fiber length, angiogenesis, and hippocampal neuronal survival and improves functional outcome after traumatic brain injury in rats.

Authors:  Ye Xiong; Changsheng Qu; Asim Mahmood; Zhongwu Liu; Ruizhuo Ning; Yi Li; David L Kaplan; Timothy Schallert; Michael Chopp
Journal:  Brain Res       Date:  2009-01-30       Impact factor: 3.252

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.